Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial

2015317 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: American Journal of Kidney Diseases

Volume 66, Issue 6, pp. 945-950

Field-Weighted Citation Impact: 24.59